English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jun 17, 2026

Edgewise Therapeutics’ cardiomyopathy drug shows mixed results in Phase 2 trial
+ Pharmaceuticals
Patient Daily | Jun 17, 2026

uniQure to submit Huntington’s gene therapy for FDA approval after agency reverses stance
+ Pharmaceuticals
Patient Daily | Jun 17, 2026

PwC reports strong biopharma M&A activity as sector shifts to precision science
+ Pharmaceuticals
Patient Daily | Jun 17, 2026

AGA urges careful consideration of colorectal cancer screening test options
+ Pharmaceuticals
Patient Daily | Jun 17, 2026

Study finds weight-loss medications may reduce risk of violent criminal behavior
+ Pharmaceuticals
Patient Daily | Jun 17, 2026

Study links onion-loving gene to lower diabetes and blood pressure risk
+ Pharmaceuticals
Patient Daily | Jun 17, 2026

Robotics and augmented reality improve precision in complex jaw surgery
+ Pharmaceuticals
Patient Daily | Jun 17, 2026

First human trial to test therapy targeting aging immune cells, UCL researchers announce

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation